Insights on Multiple Myeloma Treatment Strategies

María Victoria Mateos, Heinz Ludwig, Ali Bazarbachi, Meral Beksac, Joan Bladé, Mario Boccadoro, Michele Cavo, Michel Delforge, Meletios A. Dimopoulos, Thierry Facon, Catarina Geraldes, Hartmut Goldschmidt, Roman Hájek, Markus Hansson, Krzysztof Jamroziak, Merav Leiba, Tamás Masszi, Larisa Mendeleeva, Michael O'Dwyer, Torben PlesnerJesús F. San-Miguel, Christian Straka, Niels W.C.J. Van De Donk, Kwee Yong, Samo Zver, Philippe Moreau, Pieter Sonneveld*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.

Original languageEnglish
Article numbere163
JournalHemaSphere
Volume3
Issue number1
DOIs
Publication statusPublished - 1 Feb 2019

Cite this

Mateos, M. V., Ludwig, H., Bazarbachi, A., Beksac, M., Bladé, J., Boccadoro, M., ... Sonneveld, P. (2019). Insights on Multiple Myeloma Treatment Strategies. HemaSphere, 3(1), [e163]. https://doi.org/10.1097/HS9.0000000000000163